Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
New developments in percutaneous coronary intervention
Autore:
Kelly, RF;
Indirizzi:
Rush Presbyterian St Lukes Med Ctr, Cardiol Sect, Chicago, IL 60612 USA Rush Presbyterian St Lukes Med Ctr Chicago IL USA 60612 ago, IL 60612 USA Cook Cty Hosp, Div Cardiol, Chicago, IL 60612 USA Cook Cty Hosp Chicago IL USA 60612 sp, Div Cardiol, Chicago, IL 60612 USA
Titolo Testata:
CRITICAL CARE CLINICS
fascicolo: 2, volume: 17, anno: 2001,
pagine: 303 -
SICI:
0749-0704(200104)17:2<303:NDIPCI>2.0.ZU;2-5
Fonte:
ISI
Lingua:
ENG
Soggetto:
ACUTE MYOCARDIAL-INFARCTION; MOLECULAR-WEIGHT HEPARIN; PLACEBO-CONTROLLED TRIAL; LOW-RISK PATIENTS; QUALITY-OF-LIFE; BALLOON ANGIOPLASTY; STENT IMPLANTATION; LONG-TERM; ARTERY DISEASE; BYPASS-SURGERY;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
98
Recensione:
Indirizzi per estratti:
Indirizzo: Kelly, RF Rush Presbyterian St Lukes Med Ctr, Cardiol Sect, 1725 W Harrison St,Suite407, Chicago, IL 60612 USA Rush Presbyterian St Lukes Med Ctr 1725 W Harrison St,Suite 407 Chicago IL USA 60612
Citazione:
R.F. Kelly, "New developments in percutaneous coronary intervention", CRIT CARE C, 17(2), 2001, pp. 303

Abstract

Since Dr. Andreas Gruentzig performed the first angioplasty procedure in ahuman in 1977,(39) the technology and techniques of percutaneous coronary intervention (PCI) have developed considerably. Until relatively recently, balloon angioplasty performed in the presence of adjunctive therapy with aspirin and heparin has been the only widely available percutaneous revascularization modality. A number of new devices have been adopted into everyday clinical practice, including stents, atherectomy catheters, and others. Theuse of new pharmacologic agents as adjuncts to interventional procedures, particularly glycoprotein IIb/IIIa receptor antagonists, also has become standard. In addition, although the intra-aortic balloon pump is not a new device, the use of balloon pumps and other circulatory support devices in selected highrisk patients undergoing coronary intervention has grown. Patient selection for percutaneous revascularization has changed considerably. PCI now is performed commonly in many patients who generally were not treated with PCI in the past, including patients with acute myocardial infarction or multivessel disease. Finally, although this article is limited totherapeutic approaches for coronary artery disease, it should be recognized that the scope of percutaneous intervention now extends to procedures involving the carotid arteries, peripheral arteries, and the aorta.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 23/01/20 alle ore 07:14:05